Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 430

1.

Sleep Staging Monitoring Based on Sonar Smartphone Technology.

Zaffaroni A, Coffey S, Dodd S, Kilroy H, Lyon G, O'Rourke D, Lederer K, Fietze I, Penzel T.

Conf Proc IEEE Eng Med Biol Soc. 2019 Jul;2019:2230-2233. doi: 10.1109/EMBC.2019.8857033.

PMID:
31946344
2.

X-linked infantile spinal muscular atrophy (SMAX2) caused by novel c.1681G>A substitution in the UBA1 gene, expanding the phenotype.

Shaughnessy N, Forman EB, O'Rourke D, Lynch SA, Lynch B.

Neuromuscul Disord. 2019 Nov 14. pii: S0960-8966(19)31173-3. doi: 10.1016/j.nmd.2019.11.004. [Epub ahead of print]

PMID:
31932168
3.

Multivariate Analysis of Preoperative Magnetic Resonance Imaging Reveals Transcriptomic Classification of de novo Glioblastoma Patients.

Rathore S, Akbari H, Bakas S, Pisapia JM, Shukla G, Rudie JD, Da X, Davuluri RV, Dahmane N, O'Rourke DM, Davatzikos C.

Front Comput Neurosci. 2019 Dec 12;13:81. doi: 10.3389/fncom.2019.00081. eCollection 2019.

4.

Potential of Glioblastoma-Targeted Chimeric Antigen Receptor (CAR) T-Cell Therapy.

Salinas RD, Durgin JS, O'Rourke DM.

CNS Drugs. 2020 Jan 8. doi: 10.1007/s40263-019-00687-3. [Epub ahead of print] Review.

PMID:
31916100
5.

A Patient-Derived Glioblastoma Organoid Model and Biobank Recapitulates Inter- and Intra-tumoral Heterogeneity.

Jacob F, Salinas RD, Zhang DY, Nguyen PTT, Schnoll JG, Wong SZH, Thokala R, Sheikh S, Saxena D, Prokop S, Liu DA, Qian X, Petrov D, Lucas T, Chen HI, Dorsey JF, Christian KM, Binder ZA, Nasrallah M, Brem S, O'Rourke DM, Ming GL, Song H.

Cell. 2020 Jan 9;180(1):188-204.e22. doi: 10.1016/j.cell.2019.11.036. Epub 2019 Dec 26.

PMID:
31883794
6.

Mechanisms of resistance to CAR T cell therapies.

Singh N, Orlando E, Xu J, Xu J, Binder Z, Collins MA, O'Rourke DM, Melenhorst JJ.

Semin Cancer Biol. 2019 Dec 19. pii: S1044-579X(19)30398-0. doi: 10.1016/j.semcancer.2019.12.002. [Epub ahead of print] Review.

PMID:
31866478
7.

Immune landscapes associated with different glioblastoma molecular subtypes.

Martinez-Lage M, Lynch TM, Bi Y, Cocito C, Way GP, Pal S, Haller J, Yan RE, Ziober A, Nguyen A, Kandpal M, O'Rourke DM, Greenfield JP, Greene CS, Davuluri RV, Dahmane N.

Acta Neuropathol Commun. 2019 Nov 29;7(1):203. doi: 10.1186/s40478-019-0803-6.

8.

Rapid and ultrasensitive digital PCR (dPCR) profiling of EGFRvIII in tumor cells and tissues.

Saxena D, Sheikh S, Kao G, Binder ZA, Alonso-Basanta M, O'Rourke DM, Nasrallah MP, Dorsey JF.

Neurooncol Adv. 2019 May-Dec;1(1):vdz030. doi: 10.1093/noajnl/vdz030. Epub 2019 Nov 28.

9.

Suppression of murine osteoarthritis by 4-methylumbelliferone.

Tsuchiya S, Ohashi Y, Ishizuka S, Ishiguro N, O'Rourke DP, Knudson CB, Knudson W.

J Orthop Res. 2019 Nov 27. doi: 10.1002/jor.24541. [Epub ahead of print]

PMID:
31774188
10.

Clinical activity of the EGFR tyrosine kinase inhibitor osimertinib in EGFR-mutant glioblastoma.

Makhlin I, Salinas RD, Zhang D, Jacob F, Ming GL, Song H, Saxena D, Dorsey JF, Nasrallah MP, Morrissette JJ, Binder ZA, O'Rourke DM, Desai AS, Brem S, Bagley SJ.

CNS Oncol. 2019 Nov 1;8(3):CNS43. doi: 10.2217/cns-2019-0014. Epub 2019 Nov 15.

11.

Full genomic characterisation of an emerging infectious laryngotracheitis virus class 7b from Australia linked to a vaccine strain revealed its identity.

Sabir AJ, Olaogun OM, O'Rourke D, Fakhri O, Coppo MJC, Devlin JM, Konsak-Ilievski B, Noormohammadi AH.

Infect Genet Evol. 2019 Oct 31;78:104067. doi: 10.1016/j.meegid.2019.104067. [Epub ahead of print]

PMID:
31678646
12.

Clinical Utility of Plasma Cell-Free DNA in Adult Patients with Newly Diagnosed Glioblastoma: A Pilot Prospective Study.

Bagley SJ, Nabavizadeh SA, Mays JJ, Till JE, Ware JB, Levy S, Sarchiapone W, Hussain J, Prior T, Guiry S, Christensen T, Yee SS, Nasrallah MP, Morrissette JJD, Binder ZA, O'Rourke DM, Cucchiara AJ, Brem S, Desai AS, Carpenter EL.

Clin Cancer Res. 2020 Jan 15;26(2):397-407. doi: 10.1158/1078-0432.CCR-19-2533. Epub 2019 Oct 30.

PMID:
31666247
13.

Clinical investigation of CAR T cells for solid tumors: Lessons learned and future directions.

Bagley SJ, O'Rourke DM.

Pharmacol Ther. 2020 Jan;205:107419. doi: 10.1016/j.pharmthera.2019.107419. Epub 2019 Oct 16. Review.

PMID:
31629009
14.

Negative prognostic impact of epidermal growth factor receptor copy number gain in young adults with isocitrate dehydrogenase wild-type glioblastoma.

Hoffman DI, Abdullah KG, McCoskey M, Binder ZA, O'Rourke DM, Desai AS, Nasrallah MP, Bigdeli A, Morrissette JJD, Brem S, Bagley SJ.

J Neurooncol. 2019 Nov;145(2):321-328. doi: 10.1007/s11060-019-03298-6. Epub 2019 Sep 21.

PMID:
31542863
15.

A Randomized Double-Blind Placebo-Controlled Phase II Trial of Dendritic Cell Vaccine ICT-107 in Newly Diagnosed Patients with Glioblastoma.

Wen PY, Reardon DA, Armstrong TS, Phuphanich S, Aiken RD, Landolfi JC, Curry WT, Zhu JJ, Glantz M, Peereboom DM, Markert JM, LaRocca R, O'Rourke DM, Fink K, Kim L, Gruber M, Lesser GJ, Pan E, Kesari S, Muzikansky A, Pinilla C, Santos RG, Yu JS.

Clin Cancer Res. 2019 Oct 1;25(19):5799-5807. doi: 10.1158/1078-0432.CCR-19-0261. Epub 2019 Jul 18.

PMID:
31320597
16.

Evaluating the Association Between the Extent of Resection and Survival in Gliosarcoma.

Ahmed FI, Abdullah KG, Durgin J, Salinas RD, O'Rourke DM, Brem S.

Cureus. 2019 Apr 3;11(4):e4374. doi: 10.7759/cureus.4374.

17.

Arterial Spin Labeling and Dynamic Susceptibility Contrast-enhanced MR Imaging for evaluation of arteriovenous shunting and tumor hypoxia in glioblastoma.

Nabavizadeh SA, Akbari H, Ware JB, Nasrallah M, Guiry S, Bagley SJ, Desai A, Levy S, Sarchiapone W, Prior T, Detre J, Wolf RL, O'Rourke DM, Brem S, Davatzikos C.

Sci Rep. 2019 Jun 19;9(1):8747. doi: 10.1038/s41598-019-45312-x.

18.

Molecular Neuropathology in Practice: Clinical Profiling and Integrative Analysis of Molecular Alterations in Glioblastoma.

Nasrallah MP, Binder ZA, Oldridge DA, Zhao J, Lieberman DB, Roth JJ, Watt CD, Sukhadia S, Klinman E, Daber RD, Desai A, Brem S, O'Rourke DM, Morrissette JJD.

Acad Pathol. 2019 May 27;6:2374289519848353. doi: 10.1177/2374289519848353. eCollection 2019 Jan-Dec.

19.

Palaeo-Eskimo genetic ancestry and the peopling of Chukotka and North America.

Flegontov P, Altınışık NE, Changmai P, Rohland N, Mallick S, Adamski N, Bolnick DA, Broomandkhoshbacht N, Candilio F, Culleton BJ, Flegontova O, Friesen TM, Jeong C, Harper TK, Keating D, Kennett DJ, Kim AM, Lamnidis TC, Lawson AM, Olalde I, Oppenheimer J, Potter BA, Raff J, Sattler RA, Skoglund P, Stewardson K, Vajda EJ, Vasilyev S, Veselovskaya E, Hayes MG, O'Rourke DH, Krause J, Pinhasi R, Reich D, Schiffels S.

Nature. 2019 Jun;570(7760):236-240. doi: 10.1038/s41586-019-1251-y. Epub 2019 Jun 5.

20.

Enhanced perioperative management of children with autism: a pilot study.

Whippey A, Bernstein LM, O'Rourke D, Reddy D.

Can J Anaesth. 2019 Oct;66(10):1184-1193. doi: 10.1007/s12630-019-01410-y. Epub 2019 May 31.

PMID:
31152370
21.

Assessing variability in surgical decision making among attending neurosurgeons at an academic center.

Ramayya AG, Chen HI, Marcotte PJ, Brem S, Zager EL, Osiemo B, Piazza M, Sharma N, McClintock SD, Schuster JM, Ali ZS, Connolly P, Heuer GG, Grady MS, Kung DK, Ozturk AK, O'Rourke DM, Malhotra NR.

J Neurosurg. 2019 May 31:1-7. doi: 10.3171/2019.2.JNS182658. [Epub ahead of print]

PMID:
31151100
22.

Alignment of European Regulatory and Health Technology Assessments: A Review of Licensed Products for Alzheimer's Disease.

Dekker MJHJ, Bouvy JC, O'Rourke D, Thompson R, Makady A, Jonsson P, Gispen-de Wied CC.

Front Med (Lausanne). 2019 May 7;6:73. doi: 10.3389/fmed.2019.00073. eCollection 2019.

23.

For whom the egg thaws: insights from an analysis of 10 years of frozen egg thaw data from two UK clinics, 2008-2017.

Gürtin ZB, Morgan L, O'Rourke D, Wang J, Ahuja K.

J Assist Reprod Genet. 2019 Jun;36(6):1069-1080. doi: 10.1007/s10815-019-01429-6. Epub 2019 May 23.

PMID:
31119440
24.

The LACE+ index fails to predict 30-90 day readmission for supratentorial craniotomy patients: A retrospective series of 238 surgical procedures.

Caplan IF, Zadnik Sullivan P, Glauser G, Choudhri O, Kung D, O'Rourke DM, Osiemo B, Goodrich S, McClintock SD, Malhotra NR.

Clin Neurol Neurosurg. 2019 Jul;182:79-83. doi: 10.1016/j.clineuro.2019.04.026. Epub 2019 May 1.

PMID:
31102908
25.

Lipodisqs for eukaryote lipidomics with retention of viability: Sensitivity and resistance to Leucobacter infection linked to C.elegans cuticle composition.

Bada Juarez JF, O'Rourke D, Judge PJ, Liu LC, Hodgkin J, Watts A.

Chem Phys Lipids. 2019 Aug;222:51-58. doi: 10.1016/j.chemphyslip.2019.02.005. Epub 2019 May 15.

PMID:
31102583
26.

The Expectations and Challenges of Wildlife Disease Research in the Era of Genomics: Forecasting with a Horizon Scan-like Exercise.

Fitak RR, Antonides JD, Baitchman EJ, Bonaccorso E, Braun J, Kubiski S, Chiu E, Fagre AC, Gagne RB, Lee JS, Malmberg JL, Stenglein MD, Dusek RJ, Forgacs D, Fountain-Jones NM, Gilbertson MLJ, Worsley-Tonks KEL, Funk WC, Trumbo DR, Ghersi BM, Grimaldi W, Heisel SE, Jardine CM, Kamath PL, Karmacharya D, Kozakiewicz CP, Kraberger S, Loisel DA, McDonald C, Miller S, O'Rourke D, Ott-Conn CN, Páez-Vacas M, Peel AJ, Turner WC, VanAcker MC, VandeWoude S, Pecon-Slattery J.

J Hered. 2019 May 7;110(3):261-274. doi: 10.1093/jhered/esz001.

PMID:
31067326
27.

Vaccination with FAdV-8a induces protection against inclusion body hepatitis caused by homologous and heterologous strains.

Steer-Cope PA, Sandy JR, O'Rourke D, Scott PC, Browning GF, Noormohammadi AH.

Avian Pathol. 2019 Oct;48(5):396-405. doi: 10.1080/03079457.2019.1612032. Epub 2019 Jun 14.

PMID:
31042049
28.

Transcriptome signatures associated with meningioma progression.

Viaene AN, Zhang B, Martinez-Lage M, Xiang C, Tosi U, Thawani JP, Gungor B, Zhu Y, Roccograndi L, Zhang L, Bailey RL, Storm PB, O'Rourke DM, Resnick AC, Grady MS, Dahmane N.

Acta Neuropathol Commun. 2019 Apr 30;7(1):67. doi: 10.1186/s40478-019-0690-x.

29.

A novel CRISPR/Cas9 associated technology for sequence-specific nucleic acid enrichment.

Stevens RC, Steele JL, Glover WR, Sanchez-Garcia JF, Simpson SD, O'Rourke D, Ramsdell JS, MacManes MD, Thomas WK, Shuber AP.

PLoS One. 2019 Apr 18;14(4):e0215441. doi: 10.1371/journal.pone.0215441. eCollection 2019.

30.

Mutation of oppF gene in the Mycoplasma synoviae MS-H vaccine strain and its implication for differential serological responses to vaccination versus field challenge.

Kordafshari S, Marenda MS, O'Rourke D, Shil P, Noormohammadi AH.

Vet Microbiol. 2019 Apr;231:48-55. doi: 10.1016/j.vetmic.2019.02.029. Epub 2019 Feb 22.

PMID:
30955823
31.

LACE+ Index as Predictor of 30-Day Readmission in Brain Tumor Population.

Caplan IF, Sullivan PZ, Kung D, O'Rourke DM, Choudhri O, Glauser G, Osiemo B, Goodrich S, McClintock SD, Malhotra NR.

World Neurosurg. 2019 Jul;127:e443-e448. doi: 10.1016/j.wneu.2019.03.169. Epub 2019 Mar 27.

PMID:
30926557
32.

Ethical and moral considerations of (patient) centredness in nursing and healthcare: Navigating uncharted waters.

O'Rourke DJ, Thompson GN, McMillan DE.

Nurs Inq. 2019 Jul;26(3):e12284. doi: 10.1111/nin.12284. Epub 2019 Mar 27.

PMID:
30916429
33.

Detection of occult neoplastic infiltration in the corpus callosum and prediction of overall survival in patients with glioblastoma using diffusion tensor imaging.

Mohan S, Wang S, Coban G, Kural F, Chawla S, O'Rourke DM, Poptani H.

Eur J Radiol. 2019 Mar;112:106-111. doi: 10.1016/j.ejrad.2019.01.015. Epub 2019 Jan 15.

PMID:
30777198
34.

Influence of stems and metaphyseal sleeve on primary stability of cementless revision tibial trays used to reconstruct AORI IIB defects.

Awadalla M, Al-Dirini RMA, O'Rourke D, Solomon LB, Heldreth M, Rullkoetter P, Taylor M.

J Orthop Res. 2019 May;37(5):1033-1041. doi: 10.1002/jor.24232. Epub 2019 Apr 7.

PMID:
30677164
35.

Molecular analysis of an ancient Thule population at Nuvuk, Point Barrow, Alaska.

Tackney J, Jensen AM, Kisielinski C, O'Rourke DH.

Am J Phys Anthropol. 2019 Feb;168(2):303-317. doi: 10.1002/ajpa.23746.

PMID:
30628076
36.

Investigation onto the correlation between systemic antibodies to surface glycoproteins of infectious laryngotracheitis virus (ILTV) and protective immunity.

Sabir AJ, Adams TE, O'Rourke D, Devlin JM, Noormohammadi AH.

Vet Microbiol. 2019 Jan;228:252-258. doi: 10.1016/j.vetmic.2018.12.010. Epub 2018 Dec 11.

PMID:
30593375
37.

AKT/mTORC2 Inhibition Activates FOXO1 Function in CLL Cells Reducing B-Cell Receptor-Mediated Survival.

Cosimo E, Tarafdar A, Moles MW, Holroyd AK, Malik N, Catherwood MA, Hay J, Dunn KM, Macdonald AM, Guichard SM, O'Rourke D, Leach MT, Sansom OJ, Cosulich SC, McCaig AM, Michie AM.

Clin Cancer Res. 2019 Mar 1;25(5):1574-1587. doi: 10.1158/1078-0432.CCR-18-2036. Epub 2018 Dec 17.

38.

Three-dimensional echo planar spectroscopic imaging for differentiation of true progression from pseudoprogression in patients with glioblastoma.

Verma G, Chawla S, Mohan S, Wang S, Nasrallah M, Sheriff S, Desai A, Brem S, O'Rourke DM, Wolf RL, Maudsley AA, Poptani H.

NMR Biomed. 2019 Feb;32(2):e4042. doi: 10.1002/nbm.4042. Epub 2018 Dec 17.

39.

Relation of Venous Thromboembolism Risk to Ischemic Stroke Risk in Hospitalized Patients with Cancer.

Corley AM, Sullivan MJ, Friedman SE, O'Rourke DJ, Palac RT, Gemignani AS.

Am J Cardiol. 2019 Feb 15;123(4):679-683. doi: 10.1016/j.amjcard.2018.11.008. Epub 2018 Nov 24.

PMID:
30528279
40.

Multiparametric magnetic resonance imaging in the assessment of anti-EGFRvIII chimeric antigen receptor T cell therapy in patients with recurrent glioblastoma.

Wang S, O'Rourke DM, Chawla S, Verma G, Nasrallah MP, Morrissette JJD, Plesa G, June CH, Brem S, Maloney E, Desai A, Wolf RL, Poptani H, Mohan S.

Br J Cancer. 2019 Jan;120(1):54-56. doi: 10.1038/s41416-018-0342-0. Epub 2018 Nov 27.

41.

Virtual trial to evaluate the robustness of cementless femoral stems to patient and surgical variation.

Al-Dirini RMA, Martelli S, O'Rourke D, Huff D, Zhang J, Clement JG, Besier T, Taylor M.

J Biomech. 2019 Jan 3;82:346-356. doi: 10.1016/j.jbiomech.2018.11.013. Epub 2018 Nov 15.

PMID:
30473137
42.

Regulatory and Health Technology Assessment Considerations for Disease-Modifying Drugs in Alzheimer's Disease.

Bouvy JC, Jonsson P, O'Rourke D, Chadha AS, Hedberg N, Makady A, Xoxi E, Wied CG, Schiel A, Long R, Gallacher J.

CNS Drugs. 2018 Dec;32(12):1085-1090. doi: 10.1007/s40263-018-0581-x.

43.

Nontraditional Laboratory Animal Species (Cephalopods, Fish, Amphibians, Reptiles, and Birds).

O'Rourke DP, Baccanale CL, Stoskopf MK.

ILAR J. 2018 Dec 31;59(2):168-176. doi: 10.1093/ilar/ily003.

PMID:
30462255
44.

Histopathologic quantification of viable tumor versus treatment effect in surgically resected recurrent glioblastoma.

Bagley SJ, Schwab RD, Nelson E, Viaene AN, Binder ZA, Lustig RA, O'Rourke DM, Brem S, Desai AS, Nasrallah MP.

J Neurooncol. 2019 Jan;141(2):421-429. doi: 10.1007/s11060-018-03050-6. Epub 2018 Nov 16.

PMID:
30446903
45.

Sampling strategies for approximating patient variability in population-based finite element studies of total hip replacement.

O'Rourke D, Bottema M, Taylor M.

Int J Numer Method Biomed Eng. 2019 Mar;35(3):e3168. doi: 10.1002/cnm.3168. Epub 2018 Nov 18.

PMID:
30394696
46.

New Frontiers in the Treatment of Spinal Muscular Atrophy.

Power CL, O'Rourke DJ.

Ir Med J. 2018 Mar 14;111(3):705. No abstract available.

PMID:
30376223
47.

RNA-seq for identification of therapeutically targetable determinants of immune activation in human glioblastoma.

Bagley SJ, Hwang WT, Brem S, Linette GP, O'Rourke DM, Desai AS.

J Neurooncol. 2019 Jan;141(1):95-102. doi: 10.1007/s11060-018-03010-0. Epub 2018 Oct 23.

48.

Circulating Glioma Cells Exhibit Stem Cell-like Properties.

Liu T, Xu H, Huang M, Ma W, Saxena D, Lustig RA, Alonso-Basanta M, Zhang Z, O'Rourke DM, Zhang L, Gong Y, Kao GD, Dorsey JF, Fan Y.

Cancer Res. 2018 Dec 1;78(23):6632-6642. doi: 10.1158/0008-5472.CAN-18-0650. Epub 2018 Oct 15.

49.

Checkpoint Blockade Reverses Anergy in IL-13Rα2 Humanized scFv-Based CAR T Cells to Treat Murine and Canine Gliomas.

Yin Y, Boesteanu AC, Binder ZA, Xu C, Reid RA, Rodriguez JL, Cook DR, Thokala R, Blouch K, McGettigan-Croce B, Zhang L, Konradt C, Cogdill AP, Panjwani MK, Jiang S, Migliorini D, Dahmane N, Posey AD Jr, June CH, Mason NJ, Lin Z, O'Rourke DM, Johnson LA.

Mol Ther Oncolytics. 2018 Aug 28;11:20-38. doi: 10.1016/j.omto.2018.08.002. eCollection 2018 Dec 21.

50.

PDGF-mediated mesenchymal transformation renders endothelial resistance to anti-VEGF treatment in glioblastoma.

Liu T, Ma W, Xu H, Huang M, Zhang D, He Z, Zhang L, Brem S, O'Rourke DM, Gong Y, Mou Y, Zhang Z, Fan Y.

Nat Commun. 2018 Aug 27;9(1):3439. doi: 10.1038/s41467-018-05982-z.

Supplemental Content

Loading ...
Support Center